1. Signaling Pathways
  2. Others
  3. Drug Isomer
  4. Drug Isomer Control

Drug Isomer Control

Drug Isomer Controls (20):

Cat. No. Product Name Effect Purity
  • HY-N0521
    (-)-Gallocatechin
    Control 99.96%
    (-)-Gallocatechin, an epimer of (-)-Epigallocatechin (EGC), is contained in various tea products. (-)-Gallocatechin has antioxidant activities.
  • HY-76542B
    (R)-Vitamin D2
    Control 98.67%
    (R)-Vitamin D2 is the isomer of Vitamin D2 (HY-76542), and can be used as an experimental control. Vitamin D2 (Ergocalciferol), drived from plant sources or dietary supplements, could be used as supplement of Vitamin D.
  • HY-110258B
    (R,S,R)-ML334
    Control 98.57%
    (R,S,R)-ML334 is the isomer of ML334 (HY-110258), and can be used as an experimental control. ML334 is a potent, cell permeable activator of NRF2 by inhibition of Keap1-NRF2 protein-protein interaction. ML334 binds to Keap1 Kelch domain with a Kd of 1 μM. ML334 stimulates NRF2 expression and nuclear translocation and induces antioxidant response elements (ARE) activity.
  • HY-124883
    R-(–)-Flecainide
    Control 99.90%
    R-(–)-Flecainide is an orally active antiarrhythmic agent, which inhibits ventricular ectopic activity.
  • HY-100540C
    Golgicide A-1
    Control 99.94%
    Golgicide A-1 (GCA-1) is a less active cis-diastereomer of Golgicide A (GCA). Golgicide A-1 weakly inhibits mosquito reproduction.
  • HY-N7199
    (Rac)-Hydnocarpin
    Control
    (Rac)-Hydnocarpin is a flavonoid isolated from Hydnocarpus anthelminthica, and exhibits moderate cytotoxic on cancer cells.
  • HY-145388B
    AU-16235
    Control 99.52%
    AU-16235 is an inactive epimer of AU-15330. AU-16235 has no effect on cancer cell survival and growth
  • HY-107842
    (Z)-JIB-04
    Control 99.42%
    (Z)-JIB-04 (NSC693627) is the Z isomer of JIB-04 that has two forms, E (HY-13953) and Z isomers. (Z)-JIB-04 is inactive in epigenetic analysis.
  • HY-139534A
    (S)-ARI-1
    Control 99.80%
    (S)-ARI-1 is an S-enantiomer of ARI-1. ARI-1 is a ROR1 inhibitor and apoptosis inducer, used in NSCLC research.
  • HY-145572B
    (S)-Imlunestrant tosylate
    Control 98.74%
    (S)-Imlunestrant ((S)-LY-3484356) tosylate is an (S)-enantiomer of Imlunestrant (HY-145572). (S)-Imlunestrant tosylate can be used in research of cancer.
  • HY-126069
    15(R)-Iloprost
    Control
    15(R)-Iloprost is the unnatural or inverted C-15 epimer of lloprost (HY-A0096).
  • HY-N6008A
    7β-O-Methylmorroniside
    Control
    7β-O-Methylmorroniside (7R-O-methylmorroniside) is a R-isomer of 7-O-Methyl morroniside.
  • HY-15344A
    (S,S)-Ketone monoester
    Control
    (S,S)-Ketone monoester is a (S,S)-enantiomer of Ketone monoester (HY-15344). Ketone monoester elevates the AcAc and acetone levels, thereby produces sustained ketosis and significantly delays central nervous system oxygen toxicity (CNS-OT) seizures.
  • HY-113887A
    11β-Prostaglandin F1β
    Control
    11β-Prostaglandin F (11β-PGF) is a stereoisomer of PGF with inverted C-9 and C-11 hydroxyl groups.
  • HY-139553A
    (R)-Zunsemetinib
    Control
    (R)-Zunsemetinib is the isomer of Zunsemetinib (HY-139553), and can be used as an experimental control. Zunsemetinib (CDD-450) is an orally active and selective p38α mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway inhibitor. Zunsemetinib can be used for the research of immuno-inflammatory diseases.
  • HY-117799C
    (±)-LY-426965 dihydrochloride
    Control
    (±)-LY-426965 dihydrochloride is a racemate of LY-426965 (HY-117799). LY426965 is a potent 5-HT1A receptor antagonist.
  • HY-W202854
    Methiopropamine 3’-thiophene isomer hydrochloride
    Control
    Methiopropamine 3’-thiophene isomer is an isomer of Methiopropamine that has the sulfur atom of the thiophene group at the 3 position.
  • HY-113145
    (Rac)-Salvianic acid A
    Control
    (Rac)-Salvianic acid A is the racemate of Salvianic acid A (HY-N1913). Salvianic acid A, an orally active phenolic compound, can induce Nrf2/HO-1 activation and inhibition of NF-κB pathway. Danshensu has anti-oxidation, anti-apoptosis, anti-lung inflammatory and has the potential for COVID-19, cardiovascular and cerebrovascular diseases research.
  • HY-125922
    (22R)-Budesonide
    Control
    (22R)-Budesonide ((22R)-BUD) is the (22R)-enantiomer of Budesonide (HY-13580). (22R)-Budesonide is a non-halogenated glucocorticoid with high local anti-inflammatory activity.
  • HY-Z3151
    3'-(2-Fluorophenyl) ezetimibe
    Control
    3'-(2-Fluorophenyl) ezetimibe is an isomer of the cholesterol transport inhibitor Ezetimibe (HY-17376).